| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/11/2009 | CA2482551C 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists |
| 08/11/2009 | CA2395846C Diazepan derivatives or salts thereof |
| 08/11/2009 | CA2219359C Hydantoin derivatives as intermediates for pharmaceutical active compounds |
| 08/06/2009 | WO2009097306A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity |
| 08/06/2009 | WO2009096668A2 Improved process for preparing mycophenolate mofetil |
| 08/06/2009 | WO2009096202A1 Halogenated polycyclic aromatic compound and method for producing the same |
| 08/06/2009 | WO2009096198A1 Novel biaryl derivative |
| 08/06/2009 | WO2009095726A1 Acrylamide derivatives as vanilloid receptor 1 modulators |
| 08/06/2009 | WO2009095394A1 Diazepanes as histamine h3 receptor antagonists |
| 08/06/2009 | WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | WO2009094957A1 A method for the preparation of darifenacin hydrogen bromide |
| 08/06/2009 | WO2009094845A1 5-(3-heteroaromatic ring substituted phenyl) tetrazole compounds and their uses for anti-hiv/aids |
| 08/06/2009 | WO2009054952A3 Small molecule inhibitors of parp activity |
| 08/06/2009 | WO2009007853A3 Novel polymorphs of darifenacin free base and its hydrobromide salt |
| 08/06/2009 | US20090198056 such as N-[(1S,2R)-1-Benzyl-2-hydroxy-3-(1H-imidazol-2-ylamino)-3-oxopropyl]-5-[methyl(methylsulfonyl)amino]-N'-[(1R)-1-phenylethyl]isophthalamide, used for the for treatment of Alzheimer's disease |
| 08/06/2009 | US20090198052 Method for preparing optically active piperidine compounds |
| 08/06/2009 | US20090198051 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction |
| 08/06/2009 | US20090197943 Flavonoid Dimers and Methods of Making and Using Such |
| 08/06/2009 | US20090197925 O-cyclopropyl-carboxanilides and their use |
| 08/06/2009 | US20090197884 Compounds Useful as Antagonists of CCR2 |
| 08/06/2009 | US20090197882 Indazole derivatives for the treatment of hsp90-induced diseases |
| 08/06/2009 | US20090197862 2-aminopyridine kinase inhibitors |
| 08/06/2009 | US20090197825 Novel compounds and compositions and methods of use |
| 08/06/2009 | US20090197795 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/06/2009 | US20090196912 Pyridinylamines |
| 08/06/2009 | CA2712885A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity |
| 08/06/2009 | CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/05/2009 | EP2085395A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP2084153A1 Thionucleosides and pharmaceutical applications |
| 08/05/2009 | EP2084148A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 08/05/2009 | EP2084146A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/05/2009 | EP2084131A1 Indole and benzofuran 2-carboxamide derivatives |
| 08/05/2009 | EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems |
| 08/05/2009 | EP1742707A4 Treatment of cns disorders using cns target modulators |
| 08/05/2009 | EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1475370B1 Optically active azole derivative and process for producing the same |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor |
| 08/05/2009 | EP1341786B9 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 08/05/2009 | CN101501025A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501024A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501021A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 08/05/2009 | CN101501020A Nitrate esters of piperidines |
| 08/05/2009 | CN101501006A Pyridinone and pyridazinone derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/05/2009 | CN101500997A PARP inhibitors |
| 08/05/2009 | CN101500994A 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 08/05/2009 | CN101497608A HIV protease inhibitor derivative, preparation thereof and use in antineoplastic medicament preparation |
| 08/05/2009 | CN100522959C Preparation and application of a category of 6 - aryl - 3 - cycroamido methyl pyrone derviation |
| 08/05/2009 | CN100522949C Piperazinedione compounds |
| 08/05/2009 | CN100522947C CCK-1 receptor modulators |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/05/2009 | CN100522931C 2-substituted rubrene compound and its synthesis method and application |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/04/2009 | US7569694 Coumarin compound, material for light emitting device and organic electroluminescent device |
| 08/04/2009 | US7569688 Propane-1, 3-dione derivative |
| 08/04/2009 | US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 08/04/2009 | US7569604 Heterocyclic derivatives for modulation of calcium channels |
| 08/04/2009 | US7569595 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 08/04/2009 | US7569593 Compounds and compositions as protein kinase inhibitors |
| 08/04/2009 | US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 08/04/2009 | US7569588 Biphenyl compounds useful as muscarinic receptor antagonists |
| 08/04/2009 | US7569584 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 08/04/2009 | US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome |
| 08/04/2009 | US7569577 (2S)-1-[4-({4-[3-chloro-2-fluoroanilino]-6-methoxyquinazolin-7-yl}oxy)piperidin-1-yl]-1-oxopropan-2-ol; antiproliferative agents; for treatment of cancers mediated by erbB receptor EGFR tyrosine kinases; psoriasis |
| 08/04/2009 | US7569573 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate |
| 08/04/2009 | US7569568 1-[5-(5-tert-Butyl-2-methoxy-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; inflammation, chronic inflammatory disease |
| 08/04/2009 | US7569566 Inhibitors of tyrosine kinases |
| 08/04/2009 | US7569519 Such as 2-(2-chloro-3-(3-tetrahydrofuranyl)oxymethyl-4-methylsulfonyl-benzoyl)cyclohexane-1,3-dione; for selectively controlling broad-leaved weeds and weed grasses in crops such as rice |
| 08/04/2009 | US7569516 5-substituted-1-arylpyrazole-3-carboxylic acid derivatives |
| 08/04/2009 | US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease |
| 07/30/2009 | WO2009094442A2 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | WO2009094028A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | WO2009093537A1 Fluorescent agent having ethynyl group |
| 07/30/2009 | WO2009093032A1 Phthalazinone derivatives |
| 07/30/2009 | WO2009092432A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | WO2009092293A1 Pyrollidine-based compounds |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009016526A3 Ethers of substituted 5-hydrixy-1h-indol-3-carboxylic acids, a pharmaceutical composition and a method for the production and use thereof |
| 07/30/2009 | WO2008103613A3 Hydroxylamine compounds and methods of their use |
| 07/30/2009 | US20090192315 Synthesis of heterocyclic compounds |
| 07/30/2009 | US20090192311 Crystalline and amorphous 4-cyano-n--n-pyridin-2-yl-benzamide hydrochloride |
| 07/30/2009 | US20090192194 Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them |
| 07/30/2009 | US20090192191 Substituted hydroxamic acid derivatives as tnf inhibitors |
| 07/30/2009 | US20090192179 Chroman derivatives |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | CA2712998A1 Beta-amino acid derivatives for treatment of diabetes |
| 07/30/2009 | CA2712777A1 5-fluoro pyrimidine derivatives as fungicides |
| 07/30/2009 | CA2712750A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | CA2708175A1 Phthalazinone derivatives |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2082041A2 Novel genes related to glutaminyl cyclase |
| 07/29/2009 | EP2081923A1 Certain substituted amides, method of making, and method of use thereof |